U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 61 - 70 of 131 results

Status:
Possibly Marketed Outside US
Source:
NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia
(2017)
Source URL:

Class:
PROTEIN

Status:
Possibly Marketed Outside US
Source:
NCT03051516: Phase 4 Interventional Terminated High Grade Anal Canal Intraepithelial Neoplasia
(2017)
Source URL:

Class:
PROTEIN

Status:
US Approved Rx (1977)
Source:
BLA101094
(1977)
Source URL:
First approved in 1977
Source:
BLA101094
Source URL:

Class:
POLYMER

Status:
US Approved Rx (1977)
Source:
BLA101094
(1977)
Source URL:
First approved in 1977
Source:
BLA101094
Source URL:

Class:
POLYMER

Status:
US Approved Rx (1977)
Source:
BLA101094
(1977)
Source URL:
First approved in 1977
Source:
BLA101094
Source URL:

Class:
POLYMER

Status:
US Approved Rx (1977)
Source:
BLA101094
(1977)
Source URL:
First approved in 1977
Source:
BLA101094
Source URL:

Class:
POLYMER